Oxurion Announces the Continuation of KALAHARI Phase 2, Part B Study in Diabetic Macular Edema Following Interim Analysis Read more
Mosquito Repellent Market is projected to reach $9.0 billion by 2026 Globally, at a CAGR of 5.6%, says MarketsandMarkets™ Read more
NMD Pharma Receives IND Clearance to Start a Phase II Clinical Trial of NMD670 for the Treatment of Symptoms of Spinal Muscular Atrophy Type 3 Read more
Nokia analytics software selected by BT in five-year deal to improve operators’ fixed access customer experience Read more
Roche announces U.S. collaboration with Pfizer to help patients who test positive for COVID-19 navigate risks, symptoms, testing and treatment options Read more
ObsEva Evidences Compliance with Nasdaq’s Stockholder’s Equity Rule and Announces Moratorium Dismissal Request Filing Read more
Ozop Energy Solutions, Inc. Reports Activity of its’ Wholly Owned Subsidiary Ozop Energy Systems, Inc. Read more